Nemolizumab for the treatment of refractory primary localized cutaneous amyloidosis in a nonatopic patient - Gabriela Soto-Canetti, MPH; Jiwon Park, BA; Avi Bitterman, MD; Jordan Talia, MD (JAAD Case Reports)